 <h1>Eslicarbazepine Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2>In Summary</h2><p><b>Commonly reported side effects of eslicarbazepine include:</b> ataxia, balance impairment, blurred vision, diplopia, dizziness, drowsiness, headache, nausea, tremor, vertigo, abnormal gait, asthenia, fatigue, hypersomnia, nystagmus disorder, sedated state, visual disturbance, and malaise. <b>Other side effects include:</b> psychomotor impairment, hyponatremia, amnesia, aphasia, cognitive dysfunction, confusion, disorientation, memory impairment, mental disorders, and speech disturbance.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to eslicarbazepine: oral tablet</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, eslicarbazepine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking eslicarbazepine:</p><p>
<i>Less common</i>
</p><ul>
<li>Chills</li>
<li>confusion</li>
<li>decreased urine output</li>
<li>dizziness</li>
<li>fast or irregular heartbeat</li>
<li>fever</li>
<li>increased in seizure frequency or severity</li>
<li>muscle pain or cramps</li>
<li>nausea</li>
<li>severe thirst</li>
<li>swelling of the face, ankles, or hands</li>
<li>swollen, painful, or tender lymph glands in the neck, armpit, or groin</li>
<li>unusual tiredness or weakness</li>
<li>vomiting</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Blistering, peeling, or loosening of the skin</li>
<li>bloating of the abdomen or stomach</li>
<li>changes in behavior</li>
<li>discouragement</li>
<li>difficulty breathing</li>
<li>difficulty swallowing</li>
<li>feeling sad or empty</li>
<li>hives, rash, or itching skin</li>
<li>joint or muscle pain</li>
<li>large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs</li>
<li>puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue</li>
<li>rapid, shallow breathing</li>
<li>red skin lesions, often with a purple center</li>
<li>sores, ulcers, or white spots in the mouth or on the lips</li>
<li>stomach pain</li>
<li>thoughts or attempts at killing oneself</li>
<li>upper right abdominal or stomach pain</li>
<li>yellow eyes or skin</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Agitation</li>
<li>black, tarry stools</li>
<li>bleeding gums</li>
<li>blood in the urine or stools</li>
<li>chest pain</li>
<li>cough</li>
<li>hoarseness</li>
<li>decreased awareness or responsiveness</li>
<li>fainting spells</li>
<li>general feeling of tiredness or weakness</li>
<li>headache</li>
<li>high fever</li>
<li>hostility</li>
<li>irregular heartbeat</li>
<li>irritability</li>
<li>loss of consciousness</li>
<li>lower back or side pain</li>
<li>muscle twitching</li>
<li>painful or difficult urination</li>
<li>pale skin</li>
<li>pinpoint red spots on the skin</li>
<li>rapid weight gain</li>
<li>severe sleepiness</li>
<li>sore throat</li>
<li>unusual bleeding or bruising</li>
<li>unusual drowsiness, dullness, or feeling of sluggishness</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of eslicarbazepine may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Blurred vision</li>
<li>double vision</li>
<li>sensation of spinning or constant movement</li>
<li>sleepiness</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Changes in patterns and rhythms of speech</li>
<li>heartburn</li>
<li>indigestion</li>
<li>loss of interest or pleasure</li>
<li>shakiness and unsteady walk</li>
<li>shakiness in the legs, arms, hands, or feet</li>
<li>tingling of the hands or feet</li>
<li>trembling or shaking of the hands or feet</li>
<li>trouble concentrating</li>
<li>unusual weight gain or loss</li>
</ul><p>
<!-- end oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to eslicarbazepine: oral tablet</i></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypertension</p>
<p><b>Frequency not reported</b>: Palpitations, bradycardia, tachycardia, hypotension, peripheral edema, PR interval prolongation<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash</p>
<p><b>Uncommon</b> (0.1% to 1%): Alopecia, dry skin, hyperhidrosis, erythema, skin disorder, pruritus</p>
<p><b>Frequency not reported</b>: Drug reaction with eosinophilia and systemic symptoms (DRESS), nail disorder<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (up to 16%), vomiting (up to 10%)</p>
<p><b>Common</b> (1% to 10%): Diarrhea, constipation, abdominal pain</p>
<p><b>Uncommon</b> (0.1% to 1%): Gastritis, dyspepsia, dry mouth, abdominal discomfort, abdominal distension, gingivitis, melena, toothache</p>
<p><b>Frequency not reported</b>: Duodenitis, epigastric discomfort, irritable bowel syndrome, odynophagia, stomatitis, increased appetite, decreased appetite, and ageusia<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Urinary tract infection<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Uncommon</b> (0.1% to 1%): Anemia</p>
<p><b>Rare</b> (less than 0.1%): Thrombocytopenia, leukopenia</p>
<p><b>Frequency not reported</b>: Decreased hematocrit, decreased hemoglobin<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Hyponatremia, decreased appetite</p>
<p><b>Uncommon</b> (0.1% to 1%): Electrolyte imbalance, dehydration, hypochloremia<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Falls, asthenia</p>
<p><b>Uncommon</b> (0.1% to 1%): Myalgia, bone metabolism disorder, muscular weakness, pain in extremity, back pain, neck pain<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Dizziness (up to 28%), somnolence (up to 18%), headache (up to 15%)</p>
<p><b>Common</b> (1% to 10%): Vertigo, ataxia, balance disorder, tremor, dysarthria, memory impairment</p>
<p><b>Uncommon</b> (0.1% to 1%): Coordination abnormal, memory impairment, amnesia, hypersomnia, sedation, aphasia, dysesthesia, dystonia, lethargy, parosmia, cerebellar syndrome, convulsion, peripheral neuropathy, nystagmus, speech disorder, dysarthria, burning sensation, paresthesia, migraine<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Very common</b> (10% or more): Diplopia (up to 11%)</p>
<p><b>Common</b> (1% to 10%): Blurred vision, visual impairment</p>
<p><b>Frequency not reported</b>: Oscillopsia, binocular eye movement disorder, ocular hyperemia, saccadic eye movement, eye pain<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Depression, insomnia</p>
<p><b>Uncommon</b> (0.1% to 1%): Apathy, depression, nervousness, agitation, irritability, attention deficit/hyperactivity disorder, confusional state, mood swings, crying, psychomotor retardation, psychotic disorder<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Cough</p>
<p><b>Uncommon</b> (0.1% to 1%): Epistaxis, chest pain</p>
<p><b>Frequency not reported</b>: Dysphonia<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Uncommon</b> (0.1% to 1%): Hypothyroidism<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Uncommon</b> (0.1% to 1%): Liver disorder</p>
<p><b>Frequency not reported</b>: Increased transaminases<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Fatigue, asthenia, gait disturbance, peripheral edema</p>
<p><b>Uncommon</b> (0.1% to 1%): Malaise, chills<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. Aptiom (eslicarbazepine)." Sunovion Pharmaceuticals Inc, Marlborough, MA. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about eslicarbazepine</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>30 Reviews</li>
<li>Drug class: dibenzazepine anticonvulsants</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Eslicarbazepine &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Aptiom</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Epilepsy</li>
<li>Seizures</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to eslicarbazepine: oral tablet</i></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypertension</p><p><b>Frequency not reported</b>: Palpitations, bradycardia, tachycardia, hypotension, peripheral edema, PR interval prolongation<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash</p><p><b>Uncommon</b> (0.1% to 1%): Alopecia, dry skin, hyperhidrosis, erythema, skin disorder, pruritus</p><p><b>Frequency not reported</b>: Drug reaction with eosinophilia and systemic symptoms (DRESS), nail disorder<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (up to 16%), vomiting (up to 10%)</p><p><b>Common</b> (1% to 10%): Diarrhea, constipation, abdominal pain</p><p><b>Uncommon</b> (0.1% to 1%): Gastritis, dyspepsia, dry mouth, abdominal discomfort, abdominal distension, gingivitis, melena, toothache</p><p><b>Frequency not reported</b>: Duodenitis, epigastric discomfort, irritable bowel syndrome, odynophagia, stomatitis, increased appetite, decreased appetite, and ageusia<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Urinary tract infection<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Uncommon</b> (0.1% to 1%): Anemia</p><p><b>Rare</b> (less than 0.1%): Thrombocytopenia, leukopenia</p><p><b>Frequency not reported</b>: Decreased hematocrit, decreased hemoglobin<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Hyponatremia, decreased appetite</p><p><b>Uncommon</b> (0.1% to 1%): Electrolyte imbalance, dehydration, hypochloremia<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Falls, asthenia</p><p><b>Uncommon</b> (0.1% to 1%): Myalgia, bone metabolism disorder, muscular weakness, pain in extremity, back pain, neck pain<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Dizziness (up to 28%), somnolence (up to 18%), headache (up to 15%)</p><p><b>Common</b> (1% to 10%): Vertigo, ataxia, balance disorder, tremor, dysarthria, memory impairment</p><p><b>Uncommon</b> (0.1% to 1%): Coordination abnormal, memory impairment, amnesia, hypersomnia, sedation, aphasia, dysesthesia, dystonia, lethargy, parosmia, cerebellar syndrome, convulsion, peripheral neuropathy, nystagmus, speech disorder, dysarthria, burning sensation, paresthesia, migraine<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Very common</b> (10% or more): Diplopia (up to 11%)</p><p><b>Common</b> (1% to 10%): Blurred vision, visual impairment</p><p><b>Frequency not reported</b>: Oscillopsia, binocular eye movement disorder, ocular hyperemia, saccadic eye movement, eye pain<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Depression, insomnia</p><p><b>Uncommon</b> (0.1% to 1%): Apathy, depression, nervousness, agitation, irritability, attention deficit/hyperactivity disorder, confusional state, mood swings, crying, psychomotor retardation, psychotic disorder<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Cough</p><p><b>Uncommon</b> (0.1% to 1%): Epistaxis, chest pain</p><p><b>Frequency not reported</b>: Dysphonia<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Uncommon</b> (0.1% to 1%): Hypothyroidism<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Uncommon</b> (0.1% to 1%): Liver disorder</p><p><b>Frequency not reported</b>: Increased transaminases<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Fatigue, asthenia, gait disturbance, peripheral edema</p><p><b>Uncommon</b> (0.1% to 1%): Malaise, chills<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. Aptiom (eslicarbazepine)." Sunovion Pharmaceuticals Inc, Marlborough, MA. </p><h2>More about eslicarbazepine</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>30 Reviews</li>
<li>Drug class: dibenzazepine anticonvulsants</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Eslicarbazepine &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Epilepsy</li>
<li>Seizures</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>